Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Scientific
MedTech
Boston Scientific hit by cyberattack
This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.
Ben Adams
Aug 26, 2026 7:26am
Boston Scientific cuts guidance again amid restructuring push
Jul 30, 2026 9:33am
Boston Scientific restructures, plots job cuts
Jul 28, 2026 8:45am
Boston Scientific puts $1.5B into MiRus, option to buy its TAVR
May 18, 2026 8:31am
Boston Scientific heart plug stands up to blood thinners at ACC
Mar 30, 2026 11:02am
Boston Scientific to snap up Penumbra in deal valued at $14.5B
Jan 15, 2026 8:12am
